مكتبة

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

EGFR- and Integrin α V β 3 -Targeting Peptides as Potential Radiometal-Labeled Radiopharmaceuticals for Cancer Theranostics.

Authors : Rodrigues Toledo C; The Institute for Quantitative Health Science & Engineering, Michigan State University, East Lansing, MI 48824, USA.; Tantawy AA

Subjects: Integrin alphaVbeta3*/Integrin alphaVbeta3*/Integrin alphaVbeta3*/metabolism ; ErbB Receptors*/ErbB Receptors*/ErbB Receptors*/metabolism ; ErbB Receptors*/ErbB Receptors*/ErbB Receptors*/antagonists & inhibitors

Source: International journal of molecular sciences [Int J Mol Sci] 2024 Aug 05; Vol. 25 (15). Date of Electronic Publication: 2024 Aug 05.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Distribution of EGFR fusions in 35,023 Chinese patients with solid tumors-the frequency, fusion partners and clinical outcome.

Authors : Zhang H; Department of Thoracic Surgery, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.; Wang J

Subjects: ErbB Receptors*/ErbB Receptors*/ErbB Receptors*/genetics ; Oncogene Proteins, Fusion*/Oncogene Proteins, Fusion*/Oncogene Proteins, Fusion*/genetics ; Neoplasms*/Neoplasms*/Neoplasms*/genetics

Source: World journal of surgical oncology [World J Surg Oncol] 2024 Jul 25; Vol. 22 (1), pp. 194. Date of Electronic Publication: 2024 Jul 25.Publisher: BioMed Central Country of Publication: England NLM ID: 101170544 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7819

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Two Main Cancer Biomarkers as Molecular Targets of Binase Antitumor Activity.

Authors : Dudkina E; Department of Microbiology, Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan 420008, Russia.; Ulyanova V

Subjects: Endoribonucleases*/Endoribonucleases*/Endoribonucleases*/metabolism ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy; Ribonucleases/Ribonucleases/Ribonucleases/metabolism

Source: BioMed research international [Biomed Res Int] 2024 Feb 12; Vol. 2024, pp. 8159893. Date of Electronic Publication: 2024 Feb 12 (Print Publication: 2024).Publisher: Hindawi Pub. Co Country of Publication: United States NLM ID: 101600173 Publication Model: eCollection Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Development of PET Radioisotope Copper-64-Labeled Theranostic Immunoliposomes for EGFR Overexpressing Cancer-Targeted Therapy and Imaging.

Authors : Jeong HY; Department of Biomedical Laboratory Science, Yonsei University, Wonju 26493, Republic of Korea.; Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea.

Subjects: Copper Radioisotopes* ; Doxorubicin*/Doxorubicin*/Doxorubicin*/therapeutic use ; Doxorubicin*/Doxorubicin*/Doxorubicin*/analogs & derivatives

Source: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 02; Vol. 25 (3). Date of Electronic Publication: 2024 Feb 02.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

MET fusions are targetable genomic variants in the treatment of advanced malignancies.

Authors : Sun D; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.; State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.

Subjects: Neoplasms*/Neoplasms*/Neoplasms*/drug therapy ; Neoplasms*/Neoplasms*/Neoplasms*/genetics; Humans

Source: Cell communication and signaling : CCS [Cell Commun Signal] 2024 Jan 09; Vol. 22 (1), pp. 20. Date of Electronic Publication: 2024 Jan 09.Publisher: BioMed Central Country of Publication: England NLM ID: 101170464 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-811X

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Targeted Inhibitors of EGFR: Structure, Biology, Biomarkers, and Clinical Applications.

Authors : Shaban N; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow 117997, Russia.; Laboratory for Translational Genomic Bioinformatics, Moscow Institute of Physics and Technology, Dolgoprudny 141701, Russia.

Subjects: Antibodies, Monoclonal* ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy; Humans

Source: Cells [Cells] 2023 Dec 25; Vol. 13 (1). Date of Electronic Publication: 2023 Dec 25.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

The potential of swine pseudorabies virus attenuated vaccine for oncolytic therapy against malignant tumors.

Authors : Wang G; State Key Laboratory of Vaccines for Infectious Diseases, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic ProductsNational Innovation Platform for Industry-Education Intergration in Vaccine ResearchSchool of Life Sciences, School of Public Health, Xiang An Biomedicine Laboratory, Xiamen University, Xiamen, People's Republic of China.; Cao J

Subjects: Herpesvirus 1, Suid* ; Oncolytic Virotherapy* ; Oncolytic Viruses*/Oncolytic Viruses*/Oncolytic Viruses*/genetics

Source: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Oct 27; Vol. 42 (1), pp. 284. Date of Electronic Publication: 2023 Oct 27.Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

A Multifunctional Delivery System for Remodulating Cell Behaviors of Circulating Malignant Cells to Prevent Cell Fusion.

Authors : Han D; Key Laboratory of Biomedical Polymers of Ministry of Education, Department of Chemistry, Wuhan University, Wuhan, Hubei, 430072, China.; He XY

Subjects: Endothelial Cells*/Endothelial Cells*/Endothelial Cells*/metabolism ; Neoplasms*/Neoplasms*/Neoplasms*/therapy; Humans

Source: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2023 Oct; Vol. 10 (29), pp. e2303309. Date of Electronic Publication: 2023 Aug 17.Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Promoting the activity of a receptor tyrosine phosphatase with a novel pH-responsive transmembrane agonist inhibits cancer-associated phenotypes.

Authors : Rizzo S; Department of Chemistry, Lehigh University, Bethlehem, Pennsylvania, USA.; Sikorski E

Subjects: Protein Tyrosine Phosphatases* ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy ; Neoplasms*/Neoplasms*/Neoplasms*/genetics

Source: Protein science : a publication of the Protein Society [Protein Sci] 2023 Sep; Vol. 32 (9), pp. e4742.Publisher: Cold Spring Harbor Laboratory Press Country of Publication: United States NLM ID: 9211750 Publication Model: Print Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Identification of Genes Involved in EGF-induced Apoptosis Using CRISPR/Cas9 Knockout Screening: Implications for Novel Therapeutic Targets in EGFR-Overexpressing Cancers.

Authors : Kim JS; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.

Subjects: Epidermal Growth Factor*/Epidermal Growth Factor*/Epidermal Growth Factor*/genetics ; Epidermal Growth Factor*/Epidermal Growth Factor*/Epidermal Growth Factor*/pharmacology ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy

Source: Cancer research and treatment [Cancer Res Treat] 2023 Jul; Vol. 55 (3), pp. 737-745. Date of Electronic Publication: 2023 Jan 04.Publisher: The Association Country of Publication: Korea (South) NLM ID: 101155137 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

EGFR- and Integrin α V β 3 -Targeting Peptides as Potential Radiometal-Labeled Radiopharmaceuticals for Cancer Theranostics.

Distribution of EGFR fusions in 35,023 Chinese patients with solid tumors-the frequency, fusion partners and clinical outcome.

Two Main Cancer Biomarkers as Molecular Targets of Binase Antitumor Activity.

Development of PET Radioisotope Copper-64-Labeled Theranostic Immunoliposomes for EGFR Overexpressing Cancer-Targeted Therapy and Imaging.

MET fusions are targetable genomic variants in the treatment of advanced malignancies.

Targeted Inhibitors of EGFR: Structure, Biology, Biomarkers, and Clinical Applications.

The potential of swine pseudorabies virus attenuated vaccine for oncolytic therapy against malignant tumors.

A Multifunctional Delivery System for Remodulating Cell Behaviors of Circulating Malignant Cells to Prevent Cell Fusion.

Promoting the activity of a receptor tyrosine phosphatase with a novel pH-responsive transmembrane agonist inhibits cancer-associated phenotypes.

Identification of Genes Involved in EGF-induced Apoptosis Using CRISPR/Cas9 Knockout Screening: Implications for Novel Therapeutic Targets in EGFR-Overexpressing Cancers.

اتصل بنا

اتبع